Myeloid deletion of SIRT1 suppresses collagen-induced arthritis in mice by modulating dendritic cell maturation

Experimental and Molecular Medicine

Volumn 48, Issue 3, 2016, Pages

  Woo, Seong Ji ^a   Lee, Sang Myeong ^b   Lim, Hye Song ^c   Hah, Young Sool ^d   Jung, In Duk ^e   Park, Yeong Min ^e   Kim, Hyun Ok ^c   Cheon, Yun Hong ^c   Jeon, Min Gyu ^c   Jang, Kyu Yun ^a   Kim, Kyeong Min ^a   Park, Byung Hyun ^a   Lee, Sang Il ^c  

^a Chonbuk National University Medical School   (South Korea)

^b Chonbuk National University   (South Korea)

^c Gyeongsang National University School of Medicine   (South Korea)

^d Gyeongsang National University   (South Korea)

^e Konkuk University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; MATRIX METALLOPROTEINASE; MESSENGER RNA; SIRTUIN 1; TRANSCRIPTION FACTOR AP 1; AUTACOID; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DESTRUCTION; CELL MATURATION; CELLULAR IMMUNITY; COCULTURE; COLLAGEN-INDUCED ARTHRITIS; CONTROLLED STUDY; DENDRITIC CELL; DISEASE SEVERITY; FEMALE; GENE; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOMODULATION; INNATE IMMUNITY; JOINT DESTRUCTION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; POLARIZATION; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; ROR GAMMAT GENE; SCORING SYSTEM; SIRT1 GENE; SYMPTOM; SYNOVITIS; TH1 CELL; TH17 CELL; UPREGULATION; ANIMAL; ARTHRITIS, EXPERIMENTAL; BONE MARROW CELL; CELL DIFFERENTIATION; CYTOLOGY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPH NODE; METABOLISM; PATHOLOGY;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; CYTOKINES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; GENE DELETION; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION MEDIATORS; LYMPH NODES; MICE; MICE, KNOCKOUT; MYELOID CELLS; NF-KAPPA B; SIRTUIN 1; SYNOVITIS; TH1 CELLS; TH17 CELLS; TRANSCRIPTION FACTOR AP-1;

EID: 84978766121     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2015.124     Document Type: Article

References (31)

1. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003; 423: 356-361.
2. Michan S, Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem J 2007; 404: 1-13.
3. Lee JH, Song MY, Song EK, Kim EK, Moon WS, Han MK, et al. Overexpression of SIRT1 protects pancreatic ?-cells against cytokine toxicity by suppressing the nuclear factor-βB signaling pathway. Diabetes 2009; 58: 344-351.
4. Schug TT, Xu Q, Gao H, Peres-da-Silva A, Draper DW, Fessler MB, et al. Myeloid deletion of sirt1 induces inflammatory signaling in response to environmental stress. Mol Cell Biol 2010; 30: 4712-4721.
5. Hah YS, Lee YR, Jun JS, LimHS, Kim HO, Jeong YG, et al. A20 suppresses inflammatory responses and bone destruction in human fibroblast-like synoviocytes and in mice with collagen-induced arthritis. Arthritis Rheumatol 2010; 62: 2313-2321.
6. Tak PP, Firestein GS. NF-βB: a key role in inflammatory diseases. J Clin Invest 2001; 107: 7-11.
7. Hah YS, Cheon YH, Lim HS, Cho HY, Park BH, Ka SO, et al. Myeloid deletion of SIRT1 aggravates serum transfer arthritis in mice via nuclear factor-βB activation. PLoS ONE 2014; 9: e87733.
8. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011; 365: 2205-2219.
9. Song NY, Surh YJ. Janus-faced role of SIRT1 in tumorigenesis. Ann NY Acad Sci 2012; 1271: 10-19.
10. Zhang J, Lee SM, Shannon S, Gao B, Chen W, Chen A, et al. The type III histone deacetylase Sirt1 is essential for maintenance of T cell tolerance in mice. J Clin Invest 2009; 119: 3048-3058.
11. Gao B, Kong Q, Kemp K, Zhao YS, Fang D. Analysis of sirtuin 1 expression reveals a molecular explanation of IL-2-mediated reversal of T-cell tolerance. Proc Natl Acad Sci USA 2012; 109: 899-904.
12. Niederer F, Ospelt C, Brentano F, Hottiger MO, Gay RE, Gay S, et al. SIRT1 overexpression in the rheumatoid arthritis synovium contributes to proinflammatory cytokine production and apoptosis resistance. Ann Rheum Dis 2011; 70: 1866-1873.
13. Yang H, Lee SM, Gao B, Zhang J, Fang D. The histone deacetylase Sirtuin 1 deacetylates IRF1 and programs dendritic cells to control Th17 differentiation during autoimmune inflammation. J Biol Chem 2013; 288: 37256-37266.
14. Monach P, Hattori K, Huang H, Hyatt E, Morse J, Nguyen L, et al. The K/BxN mouse model of inflammatory arthritis: theory and practice. Methods Mol Med 2007; 136: 269-282.
15. Inglis JJ, Simelyte E, McCann FE, Criado G, Williams RO. Protocol for the induction of arthritis in C57BL/6 mice. Nat Protoc 2008; 3: 612-618.
16. Lee HS, Woo SJ, Koh HW, Ka SO, Zhou L, Jang KY, et al. Regulation of apoptosis and inflammatory responses by insulin-like growth factor binding protein 3 in fibroblast-like synoviocytes and experimental animal models of rheumatoid arthritis. Arthritis Rheumatol 2014; 66: 863-873.
17. Joosten LA, Helsen MM, Saxne T. van de Loo FA, Heinegard D, van den Berg WB. IL-1 blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-β blockade only ameliorates joint inflammation. J Immunol 1999; 163: 5049-5055.
18. Jung ID, Lee MG, Chang JH, Lee JS, Jeong YI, Lee CM, et al. Blockade of indoleamine 2, 3-dioxygenase protects mice against lipopolysaccharideinduced endotoxin shock. J Immunol 2009; 182: 3146-3154.
19. Nakahama T, Kimura A, Nguyen NT, Chinen I, Hanieh H, Nohara K, et al. Aryl hydrocarbon receptor deficiency in T cells suppresses the development of collagen-induced arthritis. Proc Natl Acad Sci USA 2011; 108: 14222-14227.
20. Brand DD, Kang AH, Rosloniec EF. Immunopathogenesis of collagen arthritis. Springer Semin Immunopathol 2003; 25: 3-18.
21. Wendling D, Vidon C, Abbas W, Guillot X, Toussirot E, Herbein G. Sirt1 activity in peripheral blood mononuclear cells from patients with rheumatoid arthritis. Joint Bone Spine 2014; 81: 462-463.
22. Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009; 361: 888-898.
23. Khan S, Greenberg JD, Bhardwaj N. Dendritic cells as targets for therapy in rheumatoid arthritis. Nat Rev Rheumatol 2009; 5: 566-571.
24. Moret FM, Hack CE, van der Wurff-Jacobs KM, Radstake TR, Lafeber FP, van Roon JA. Thymic stromal lymphopoietin (TSLP): a novel proinflammatory mediator in rheumatoid arthritis that potently activates CD1c+ myeloid dendritic cells to attract and stimulate T cells. Arthritis Rheumatol 2014; 66: 1176-1184.
25. Steinman RM, Nussenzweig MC. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci USA 2002; 99: 351-358.
26. Moser M. Dendritic cells in immunity and tolerance - do they display opposite functions?. Immunity 2003; 19: 5-8.
27. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, et al. Modulation of NF-βB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004; 23: 2369-2380.
28. Kong S, Kim S-J, Sandal B, Lee S-M, Gao B, Zhang DD, et al. The type III histone deacetylase Sirt1 protein suppresses p300-mediated histone H3 lysine 56 acetylation at Bclaf1 promoter to inhibit T cell activation. J Biol Chem 2011; 286: 16967-16975.
29. Zhang R, Chen HZ, Liu JJ, Jia YY, Zhang ZQ, Yang RF, et al. SIRT1 suppresses activator protein-1 transcriptional activity and cyclooxygenase-2 expression in macrophages. J Biol Chem 2010; 285: 7097-7110.
30. Dey S, Bakthavatchalu V, Tseng MT, Wu P, Florence RL, Grulke EA, et al. Interactions between SIRT1 and AP-1 reveal a mechanistic insight into the growth promoting properties of alumina (Al2O3) nanoparticles in mouse skin epithelial cells. Carcinogenesis 2008; 29: 1920-1929.
31. Hilkens CM, Isaacs JD. Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now?. Clin Exp Immunol 2013; 172: 148-157.